Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PORTFASTFLU

Financiado

Cerrado

Portable automated test for fast detection and surveillance of influenza

The PORTFASTFLU’s objective is to develop and validate a rapid diagnostic test for influenza that will be used as point-of-care systems in developed and developing countries. Experts and international bodies agree that the rapid d... ver más

31/12/2010

GENEWAVE

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

GENEWAVE SAS No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 8 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2010-12-31 No tenemos la información de la convocatoria

0% 75% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

GENEWAVE

940.52K€ | Lider

IKERLAN

378.66K€ | Participante

VLAAMS INSTITUUT BIOTECHNOL...

176.88K€ | Participante

CIRAD

339.54K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

FLUARRAY Development and validation of a microarray based automated d... 4M€ Cerrado

RANGER Rapid robust scaleable platform technology for fully auto... 4M€ Cerrado

PodiTrodi-EU Technology Platform for Point of Care Diagnostics for Tropic... 2M€ Cerrado

PoC-Cycle Innovative Molecular Diagnostics point of care device for MR... 71K€ Cerrado

RAPP-ID Development of RApid Point of Care test Platforms for Infect... 16M€ Cerrado

RAPP-ID Development of RApid Point-of-Care test Platforms for Infect... 16M€ Cerrado

Líder del proyecto

GENEWAVE SAS No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The PORTFASTFLU’s objective is to develop and validate a rapid diagnostic test for influenza that will be used as point-of-care systems in developed and developing countries. Experts and international bodies agree that the rapid detection of influenza is vital in combating this major threat to human health. Nucleic acid analysis is the most appropriate assay scheme for both early detection and late surveillance of influenza, and is routinely used by WHO and OIE virology reference laboratories. PORTFASTFLU's consortium aims at developing and validating a Point of Care (POC) instrument which will integrate sample preparation, nucleic acid amplification, microarray hybridization and fluorescent readout in a single system. Reaching this challenging objective is possible through the combined expertise of the partners and comprises access to several selected enabling technologies: microfluidics, on-chip sample preparation, advanced microarray techniques and reading systems with ultimate sensitivity and selectivity, access to reference and field virus samples. This Bio-Micro knowledge converges in one single instrument, allowing rapid detection (less than an hour) and simultaneous identification of influenza A and B viruses (typing and sub-typing) at widespread POC with only basic skills. Furthermore, the project also aims at realizing this goal in a format that requires little supervision and is integrated in a portable compact monolithic system for deployment in the field. The consortium of 9 partners from 5 member states brings together the various expertises needed to reach these objectives, which match exactly those of the call Health 2.3.3-4: Innovative point-of-care diagnostic tests for influenza

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores